Cimzia Rheumatoid Arthritis Approval Held Up By Safety Request
UCB receives “complete response” letter from FDA on second indication for the biologic, approved for Crohn’s disease with a REMS.
UCB receives “complete response” letter from FDA on second indication for the biologic, approved for Crohn’s disease with a REMS.